Nutrien Ltd. NTR
72.23
(1.73)
(2.34%)
as of 25 Sep
- Market cap
- $35.4B
- P/E
- 14.6×
Follow NTR
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
15.78 | 13.22 | 15.34 | 12.74 |
P/S ratio |
1.07 | 1.12 | 1.30 | 1.07 | |
P/FCF ratio |
15.01 | 16.97 | 18.39 | 16.28 | |
P/Operating CF |
(66.92) | 10.08 | (42.67) | 12.15 | |
P/B ratio |
1.13 | 1.18 | 1.44 | 1.16 | |
Price to Tangible BV |
2.52 | 2.60 | 3.19 | 2.47 | |
EV/Sales |
1.53 | 1.49 | 1.73 | 1.44 | |
EV/EBITDA |
7.27 | 6.56 | 7.68 | 6.50 | |
EV/Operating CF |
9.81 | 10.00 | 11.37 | 9.72 | |
EV/FCF |
21.46 | 22.64 | 24.39 | 21.93 | |
Quick Ratio |
0.81 | 0.58 | 0.53 | 0.83 | |
Current Ratio |
1.41 | 1.34 | 1.24 | 1.39 | |
Net Debt/EBITDA |
8.60 | 6.74 | 12.27 | 4.40 | |
Debt/Assets |
24.84% | 20.53% | 23.42% | 21.26% | |
Debt/Equity |
0.51 | 0.42 | 0.50 | 0.44 | |
Asset Turnover |
0.51 | 0.52 | 0.52 | 0.53 | |
Operating CF/Net income |
(0.92) | 5.21 | (6.50) | 2.05 | |
Capex/Depreciation |
(0.86) | (1.32) | (0.54) | (0.81) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.10% | 19.04% | 17.85% | 10.44% | |
Intangible Assets out of Total Assets |
0.27 | 0.26 | 0.26 | 0.26 | |
Share Based Compensation of Revenue |
0.47% | 0.82% | 1.92% | (0.38%) | |
Graham Net Nets |
(0.43) | (0.41) | (0.34) | (0.38) | |
Graham Number |
65.85 | 74.03 | 76.12 | 77.53 | |
Earnings Yield |
6.34% | 7.57% | 6.52% | 7.85% | |
Free Cash Flow Yield |
6.66% | 5.89% | 5.44% | 6.14% | |
Revenue per Share |
12.37 | 10.98 | 12.56 | 22.54 | |
Operating CF per Share |
(0.88) | 6.12 | (1.77) | 5.18 | |
Capex per Share |
(1.09) | (1.54) | (0.68) | (1.02) | |
Free Cash Flow per Share |
(1.97) | 4.58 | (2.44) | 4.16 | |
Cash per Share |
1.29 | 1.44 | 1.61 | 1.92 | |
Shareholders Equity per Share |
51.80 | 52.16 | 52.35 | 54.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
51.80 | 52.16 | 52.35 | 54.08 | |
Free Cash Flow |
(956.00) | 2,226.00 | (1,176.00) | 1,993.00 | |
Working Capital |
4,201.00 | 3,708.00 | 3,174.00 | 4,544.00 | |
Capital Expenditures |
(530.00) | (751.00) | (325.00) | (491.00) | |
Net Current Asset Value |
(12,199.00) | (12,187.00) | (12,256.00) | (11,450.00) | |
EV/EBIT |
12.69 | 10.72 | 12.45 | 10.52 | |
Capex to Sales |
0.09 | 0.14 | 0.05 | 0.05 | |
Net Profit Margin |
7.72% | 10.69% | 2.17% | 11.23% | |
Price to Operating Income |
8.88 | 8.03 | 9.38 | 7.81 | |
| Other line items | |||||
Average Receivables |
7,736.50 | 5,532.50 | 5,948.00 | 8,386.50 | |
Average Payables |
— | 7,961.00 | 9,127.50 | 9,024.00 | |
Average Inventory |
5,085.50 | 6,562.50 | 8,336.50 | 5,870.00 | |
Average Assets |
51,868.50 | 52,070.50 | 53,496.00 | 53,405.00 | |
Average Common Equity |
25,079.50 | 24,903.50 | 24,631.00 | 25,529.00 |
Columns are period end dates